drugset / Trial / NCT01917136
11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension
Phase 2
Completed
21 enrolled
University of Pennsylvania
Brigham and Women's Hospital · collabThe Cardiovascular Medical Research and Education Fund · collabUniversity of Maryland · collabWashington University School of Medicine · collabYale University · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This study is looking at differences in metabolism and functional imaging between pulmonary hypertension subjects with normal right ventricular function and persistent right ventricular dysfunction.
Timeline
- Start
- 2013-08
- Primary completion
- 2018-10
- Completion
- 2018-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 11C-Acetate | Diagnostic / imaging agent | 555 mbq | Intravenous |
| Subject | 11C-Acetate | Diagnostic / imaging agent | 925 mbq | Intravenous |
| Subject | [18F]Fluoro-2-deoxy-2-D-glucose | Unknown | 370 mbq | — |